Company intelligence / Profile preview

Ecuphar

Ownership: Private
Employees: ~54
Development stage: Other

Overview

Ecuphar develops and markets a broad range of commercialized veterinary products across Europe. Its portfolio includes well-known brands for animal dermatology, oral care, and urinary incontinence. The company has expanded through acquisition to strengthen its European presence. No clinical trial results are reported as the focus is on marketed products.

Therapeutic areas: DermatologyNephrologyOther
Modalities: Small moleculeBiologic
Industry: Veterinary

Partnerships

Kane Biotech Inc.Dechra Veterinary Products

Beyond the preview

Go deeper on Ecuphar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ecuphar.

Explore the full profile